Crown Princess Mette-Marit of Norway has been placed on a waiting list for a lung transplant, the Royal House announced in June 2026. Her lung disease has gotten worse and doctors now believe a transplant offers her the best chance for a longer, healthier life.

Mette-Marit has had pulmonary fibrosis—a chronic lung disease—since at least 2018, when she publicly disclosed it. Unlike a cold or infection that goes away, pulmonary fibrosis is permanent scarring of the lungs that slowly makes it harder to breathe. There is no cure. Doctors have medicines that can slow down the scarring, but they cannot undo it. When medicine stops working and the disease keeps getting worse, a lung transplant becomes the main option left.

The Royal House of Norway said her condition has deteriorated significantly. Getting on a transplant list is not a small step. Doctors run many tests first to make sure the patient is healthy enough to survive surgery. They check the heart, lungs, nutrition, and mental readiness. Once someone is on the list, it means doctors believe a new set of lungs will help them live longer than the surgery might risk their life. But patients must also not be so sick that surgery would be too dangerous.

How long patients wait depends on blood type, body size, and how urgent their need is. The Nordic countries share donor organs through a network called Scandiatransplant. Some urgent cases get lungs within weeks. Others wait for months. Survival after a lung transplant for this disease has improved over time. People now typically live five to six years after the surgery in good hospitals, and some live even longer. But the surgery itself carries real risks.

Mette-Marit is married to Crown Prince Haakon, Norway's heir to the throne. Her openness about her illness is unusual for a senior royal—most keep health problems private. Whether her public story about pulmonary fibrosis will lead to more research funding and better treatments is not yet clear. But when famous people speak openly about rare diseases, it often draws attention and support from the public and lawmakers.